Exploring the relationship between psoriasis and vitamin D
DOI:
https://doi.org/10.12775/JEHS.2024.71.56197Keywords
psoriasis, vitamin D, obesityAbstract
Introduction and purpose: Psoriasis is a chronic, inflammatory skin condition that affects millions of individuals worldwide. Recent research has suggested a potential link between psoriasis and vitamin D deficiency. This review paper aims to examine the existing literature on the relationship between psoriasis and vitamin D, exploring the potential role of vitamin D in the pathogenesis and management of this debilitating skin disorder.
Materials and method: An extensive examination of articles published in scientific journals was carried out through online research platforms PubMed and Google Scholar. We searched articles by entering keywords in appropriate configuration: “psoriasis”, “vitamin D”, “obesity”.
Description of the state of knowledge: Emerging research has identified a connection between vitamin D and the development of various skin conditions, including psoriasis. Consistent findings have shown a significant association between low vitamin D levels and the presence of psoriasis. Furthermore, due to vitamin D's influence on the proliferation and maturation of keratinocytes, it has become an important local treatment option for managing psoriasis.
Summary: Although there is no clear consensus on whether sufficient dietary vitamin D or oral vitamin D supplements effectively treat psoriasis, the available evidence is still inconclusive. However, healthcare providers like nutritionists should consider recommending general vitamin D supplementation for populations at high risk of vitamin D deficiency, such as those with psoriasis or obesity.
References
Zeng, J., Luo, S., Huang, Y., & Lu, Q. (2017). Critical role of environmental factors in the pathogenesis of psoriasis [Review of Critical role of environmental factors in the pathogenesis of psoriasis]. The Journal of Dermatology, 44(8), 863. Wiley. https://doi.org/10.1111/1346-8138.13806
Zhou X., Chen Y., Cui L., Shi Y., Guo C. Advances in the Pathogenesis of Psoriasis: From Keratinocyte Perspective. Cell Death Dis. 2022;13:81. doi: 10.1038/s41419-022-04523-3. (n.d.).
Cherubin M., Tebar W.R., Meneghini V., Bensenor I.M. Psoriasis and Associated Risk Factors: A Cross-Sectional Analysis of the Brazilian Longitudinal Study of Adult Health. Rev. Assoc. Med. Bras. 1992. 2023;69:e20230038. doi: 10.1590/1806-9282.20230038. (n.d.).
Parisi R, Iskandar IYK, Kontopantelis E et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysisand modelling study. BMJ 2020; 369:m1590. (n.d.).
Al‐Shobaili, H. A., Shahzad, M., Al-Marshood, A., Khalil, A., Settin, A., & Barrimah, I. (2010). Genetic background of psoriasis. In H. A. Al‐Shobaili, M. Shahzad, A. Al-Marshood, A. Khalil, A. Settin, & I. Barrimah, PubMed. National Institutes of Health. https://pubmed.ncbi.nlm.nih.gov/21475522
Navarro-Triviño F.J., Arias-Santiago S., Gilaberte-Calzada Y. Vitamin D and the Skin: A Review for Dermatologists. Actas Dermo-Sifiliogr. Engl. Ed. 2019;110:262–272. doi: 10.1016/j.ad.2018.08.006. (n.d.).
Umar M., Sastry K.S., Al Ali F., Al-Khulaifi M., Wang E., Chouchane A.I. Vitamin D and the Pathophysiology of Inflammatory Skin Diseases. Ski. Pharmacol. Physiol. 2018;31:74–86. doi: 10.1159/000485132. . (n.d.).
Soleymani T, Hung T, Soung J. The role of vitamin D in psoriasis: a review. Int J Dermatol. 2015;54(4):383–92. (1 C.E.).
Napolitano M, Caso F, Scarpa R, Megna M, Patrì A, Balato N, Costa L. Psoriatic arthritis and psoriasis: differential diagnosis. Clin Rheumatol. 2016;35(8):1893–901. (1 C.E.).
Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012;26(Suppl 2):3–11. (1 C.E.).
Patel, M., Day, A., Warren, R. B., & Menter, A. (2012). Emerging Therapies for the Treatment of Psoriasis. In M. Patel, A. Day, R. B. Warren, & A. Menter, Dermatology and Therapy (Vol. 2, Issue 1). Adis, Springer Healthcare. https://doi.org/10.1007/s13555-012-0016-4
Strober, B., Walt, J. M. van der, Armstrong, A. W., Bourcier, M., Carvalho, A. V. E. de, Chouela, E., Cohen, A. D., Cruz, C., Ellis, C. N., Finlay, A. Y., Gottlieb, A. B., Guðjónsson, J. E., Iversen, L., Kleyn, C. E., Leonardi, C. L., Lynde, C., Ryan, C., Theng, C., Valenzuela, F., … Kimball, A. B. (2018). Clinical Goals and Barriers to Effective Psoriasis Care. In B. Strober, J. M. van der Walt, A. W. Armstrong, M. Bourcier, A. V. E. de Carvalho, E. Chouela, A. D. Cohen, C. Cruz, C. N. Ellis, A. Y. Finlay, A. B. Gottlieb, J. E. Guðjónsson, L. Iversen, C. E. Kleyn, C. L. Leonardi, C. Lynde, C. Ryan, C. Theng, F. Valenzuela, … A. B. Kimball, Dermatology and Therapy (Vol. 9, Issue 1, p. 5). Adis, Springer Healthcare. https://doi.org/10.1007/s13555-018-0279-5
Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227–55. (1 C.E.).
Ljosaa T.M., Stubhaug A., Mork C., Moum T., Wahl A.K. Improvement in Psoriasis Area and Severity Index Score Predicts Improvement in Skin Pain over Time in Patients with Psoriasis. Acta Derm. Venereol. 2013;93:330–334. doi: 10.2340/00015555-1456. . (n.d.).
Dyring-Andersen B., Bonefeld C.M., Bzorek M., Løvendorf M.B., Lauritsen J.P.H., Skov L., Geisler C. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand. J. Immunol. 2015;82:84–91. doi: 10.1111/sji.12304. (n.d.).
Stanescu A.M.A., Simionescu A.A., Diaconu C.C. Oral Vitamin D Therapy in Patients with Psoriasis. Nutrients. 2021;13:163. doi: 10.3390/nu13010163. (n.d.).
Wadhwa B, Relhan V, Goel K, Kochhar AM, Garg VK. Vitamin D and skin diseases: a review. Indian J Dermatol Venereol Leprol. 2015;81(4):344–55. (1 C.E.).
Bikle DD. Protective actions of vitamin D in UVB induced skin cancer. Photochem Photobiol Sci. 2012;11(12):1808–16. (1 C.E.).
Matsumoto K, Hashimoto K, Nishida Y, Hashiro M, Yoshikawa K. Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun. 1990;166(2):916–23. (1 C.E.).
Gniadecki R. Stimulation versus inhibition of keratinocyte growth by 1,25-dihydroxyvitamin D3: dependence on cell culture conditions. J Invest Dermatol. 1996;106(3):510–6. (1 C.E.).
Umar, M., Sastry, K. S., Ali, F. A., Al-Khulaifi, M., Wang, E., & Chouchane, A. I. (2018). Vitamin D and the Pathophysiology of Inflammatory Skin Diseases [Review of Vitamin D and the Pathophysiology of Inflammatory Skin Diseases]. Skin Pharmacology and Physiology, 31(2), 74. Karger Publishers. https://doi.org/10.1159/000485132
Luan C, Chen X, Hu Y, Hao Z, Osland JM, Chen X, Gerber SD, Chen M, Gu H, Yuan R. Overexpression and potential roles of NRIP1 in psoriasis. Oncotarget. 2016; doi:10.18632/oncotarget.12371. (1 C.E.).
Buckner JH. Mechanisms of impaired regulation by CD4(+) CD25(+) FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol. 2010;10:849–59. (1 C.E.).
Van Etten E, Decallone B, Verlinden L, Verstuyf A, Bouillon R, Mathieu C, et al. Analogs of 1α,25-dihydroxy vitamin D3 as pluripotent immunomodulators. J Cell Biochem. 2003;88:223–6.Return to ref 29 in article. (1 C.E.).
Mattozzi C, Paolino G, Richetta AG, Calvieri S. Psoriasis, vitamin D and the importance of the cutaneous barrier’s integrity: an update. J Dermatol. 2016;43(5):507–14. (1 C.E.).
Finamor, D. C., Sinigaglia‐Coimbra, R., Neves, L. C. M. das, Gutierrez, M., Silva, J. J., Torres, L. D., Surano, F., Neto, D. J., Novo, N. F., Juliano, Y., Lopes, A. C., & Coimbra, C. G. (2013). A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. In D. C. Finamor, R. Sinigaglia‐Coimbra, L. C. M. das Neves, M. Gutierrez, J. J. Silva, L. D. Torres, F. Surano, D. J. Neto, N. F. Novo, Y. Juliano, A. C. Lopes, & C. G. Coimbra, Dermato-Endocrinology (Vol. 5, Issue 1, p. 222). Taylor & Francis. https://doi.org/10.4161/derm.24808
Richetta AG, Silvestri V, Giancristoforo S, Rizzolo P, D’Epiro S, Graziano V, Mattozzi C, Navazio AS, Campoli M, D’Amico C, Scarnò M, Calvieri S, Ottini L. A-1012G promoter polymorphism of vitamin D receptor gene is associated with psoriasis risk and lower allele-specific expression. DNA Cell Biol. 2014;33(2):102–9.Return to ref 31 in article. (1 C.E.).
Visconti B, Paolino G, Carotti S, Pendolino AL, Morini S, Richetta AG, Calvieri S. Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin. J Eur Acad Dermatol Venereol. 2015;29:2038–42. (1 C.E.).
Calton EK, Keane KN, Newsholme P, Soares MJ. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS One. 2015;10(11):e0141770. (1 C.E.).
Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012;67:931–8. (1 C.E.).
Bhat, G.H., Guldin, S., Khan, M.S. et al. Vitamin D status in Psoriasis: impact and clinical correlations. BMC Nutr 8, 115 (2022). https://doi.org/10.1186/s40795-022-00610-y. (1 C.E.).
Zuchi MF, Azevedo Pde O, Tanaka AA, Schmitt JV, Martins LE. Serum levels of 25-hydroxy vitamin D in psoriatic patients. An Bras Dermatol. 2015;90(3):430–2. (1 C.E.).
Mostafa WZ, Hegazy RA. Vitamin D and the skin: focus on a complex relationship: a review. J Adv Res. 2015;6(6):793–804. (1 C.E.).
Napolitano M, Megna M, Balato A, Ayala F, Lembo S, Villani A, Balato N. Systemic treatment of pediatric psoriasis: a review. Dermatol Ther (Heidelb). 2016;6(2):125–42. (1 C.E.).
Van Der Kerkhof PC. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol. 1995;132:675–82.Return to ref 59 in article. (1 C.E.).
Peric M, Koglin S, Dombrowski Y, Gross K, Bradac E, Büchau A, et al. Vitamin D analog differentially control antimicrobial peptide/"alarmin" expression in psoriasis. PLoS One. 2009;4:e6340. (1 C.E.).
Barrea L, Balato N, Di Somma C, Macchia PE, Napolitano M, Savanelli MC, Esposito K, Colao A, Savastano S. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? J Transl Med. 2015;13:18. doi:10.1186/s12967-014-0372-1. (1 C.E.).
Cashman KD. Vitamin D: Dietary requirements and food fortification as a means of helping achieve adequate vitamin D status. J Steroid Biochem Mol Biol. 2015;148:19–26. (1 C.E.).
Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, Feskens EJ, Gallagher CJ, Hypponen E, Llewellyn DJ, Stoecklin E, Dierkes J, Kies AK, Kok FJ, Lamberg-Allardt C, Moser U, Pilz S, Saris WH, van Schoor NM, Weber P, Witkamp R, Zittermann A, de Groot LC. Vitamin D: Do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int 2013;24(5):1567–1577. (1 C.E.).
Perez A, Raab R, Chen TC, Turner A, Holick MF. Safety and efficacy of oral calcitriol (1,25 dihydroxyvitamin D) for the treatment of psoriasis. Br J Dermatol. 1996;134:1070–8. (1 C.E.).
Fu LW, Vender R. Systemic role for vitamin d in the treatment of psoriasis and metabolic syndrome. Dermatol Res Pract. 2011;2011:276079. (1 C.E.).
Ezquerra GM, Regana MS, Millet PU. Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis. Acta Derma Venereol. 2007;87:449–50. (1 C.E.).
Formisano E, Proietti E, Borgarelli C, Pisciotta L. Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis. Nutrients. 2023 Jul 30;15(15):3387. doi: 10.3390/nu15153387. PMID: 37571324; PMCID: PMC10421389. (1 C.E.).
Hambly R, Kirby B. The relevance of serum vitamin D in psoriasis: a review. Arch Dermatol Res 2017; 309:499–517. (1 C.E.).
Wilson PB. Serum 25-hydroxyvitamin D status in individuals with psoriasis in the general population. Endocrine 2013; 44:537–9. (1 C.E.).
Zhang Y, Jing D, Zhou G et al. Evidence of a causal relationship between vitamin D status and risk of psoriasis from the UK Biobank study. Front Nutr 2022; 9:807344. (1 C.E.).
Carrascosa JM, Rocamora V, Fernandez-Torres RM, Jimenez-Puya R, Moreno JC, Coll-Puigserver N, et al. Obesity and psoriasis: inflammatory nature of obesity, relationship between psoriasis and obesity, and therapeutic implications. Actas Dermosifiliogr. 2014;105:31–44. (1 C.E.).
Debbaneh M, Millsop JW, Bhatia BK, Koo J, Liao W. Diet and psoriasis, part I: impact of weight loss interventions. J Am Acad Dermatol. 2014;71:133–40. (1 C.E.).
Toussirot E, Aubin F, Dumoulin G. Relationships between adipose tissue and psoriasis, with or without arthritis. Front Immunol. 2014;5:368. (1 C.E.).
Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes. 2012;36:387–96. (1 C.E.).
Marita Jenssen, Anne-Sofie Furberg, Rolf Jorde, Tom Wilsgaard, Kjersti Danielsen, The association between serum 25-hydroxyvitamin D levels and psoriasis in a large population-based cohort: a cross-sectional analysis of The Tromsø Study 2015–16, British Journal of Dermatology, Volume 190, Issue 5, May 2024, Pages 680–688, https://doi.org/10.1093/bjd/ljad472. (1 C.E.).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aleksandra Kiełczewska, Grzegorz Szcześniak, Anna Kiełczewska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 2
Number of citations: 0
